1.Sales and profit
See section β- Oxford Square Capital Corp. had $21.1M of revenue in fiscal 2025, down 15.4% on the year before.
- Oxford Square Capital Corp. lost $18.7M in fiscal 2025.
OXSQ Nasdaq Financials FY2020βFY2025
Oxford Square Capital Corp. had $21.1M of revenue in fiscal 2025, down 15.4% on the year before.
Last close Β· Oct 23, 2026
$1.30
2.3%Hi! I read Oxford Square Capital Corp.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β15.4%
No. Sales fell 15.4% last year.
Does it make a profit?
β88.8%
No. It lost money last year.
How is the share priced?
5.7x
One share costs 5.7 times its yearly profit per share.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· Oxford Square Capital Corp. had $21.1M of revenue in fiscal 2025, down 15.4% on the year before.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Oxford Square Capital Corp. lost $18.7M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
Diluted EPS
How much cash comes in, and where does it go?
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
KIRA Β· Oxford Square Capital Corp. returned $31.3M to shareholders in fiscal 2025. The diluted share count rose 20.4%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· In the last 12 months, insiders bought $0.3M and sold $0.0M of shares on the open market.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.3M
2 insiders
Sold, 12 months
$0.0M
1 insider
Of sales under plans
0%
$0.0M
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably Oxford Square Capital Corp. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $9.0M | $9.0M | $5.7M | $34.9M | $51.9M |
| Debt incl. finance leases | β | β | $129M | β | β |
| Debt / equity | β | β | 0.9x | β | β |
| Total assets | $434M | $328M | $278M | $300M | $307M |
| Total liabilities | $189M | $189M | $126M | $139M | $161M |
| Shareholders' equity | $245M | $139M | $151M | $161M | $145M |
| Net debt (β = net cash) | β | β | $123M | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 1 | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β | 33.9% | β27.8% | β15.9% | β6.9% | β1.6% |
| Altman Z'' | β | β | β | β | β | β |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | β | $17.4M | $25.2M | $33.6M | $24.9M | $21.1M |
| Net interest income | β | $17.4M | $25.2M | $33.6M | $24.9M | $21.1M |
| Interest expense | $7.9M | $10.5M | $12.4M | $10.8M | $7.8M | $9.2M |
| Net income | β | $39.6M | β$85.6M | $17.2M | $5.9M | β$18.7M |
| Diluted EPS | β | $0.32 | $0.42 | $0.51 | $0.42 | $0.30 |
| Diluted shares | β | 0.05B | 0.05B | 0.05B | 0.06B | 0.08B |
| Cash flow | ||||||
| Cash from operations | $95.1M | β$107M | $20.4M | $65.5M | $25.7M | β$13.7M |
| Dividends paid | $30.1M | $20.4M | $20.4M | $28.6M | $25.8M | $31.3M |
| Dividends and buybacks | $30.1M | $20.4M | $20.4M | $28.6M | $25.8M | $31.3M |
| Balance sheet | ||||||
| Cash and short-term investments | $59.1M | $9.0M | $9.0M | $5.7M | $34.9M | $51.9M |
| Total debt | β | β | β | $129M | β | β |
| Total assets | β | $434M | $328M | $278M | $300M | $307M |
| Total liabilities | β | $189M | $189M | $126M | $139M | $161M |
| Shareholders' equity | $225M | $245M | $139M | $151M | $161M | $145M |
| Margins | ||||||
| Net margin | β | 227.0% | β339.0% | 51.3% | 23.6% | β88.8% |
| Net interest share of revenue | β | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Returns | ||||||
| Return on equity | β | 16.8% | β44.6% | 11.9% | 3.8% | β12.2% |
| Return on assets | β | 9.1% | β22.5% | 5.7% | 2.0% | β6.2% |
| Return on tangible equity | β | 16.2% | β61.7% | 11.4% | 3.7% | β12.9% |
| Growth | ||||||
| Revenue growth | β | β | 44.7% | 33.1% | β25.8% | β15.4% |
| Net income growth | β | β | β316.1% | β | β65.9% | β418.6% |
| EPS growth | β | β | 31.3% | 21.4% | β17.6% | β28.6% |
| Share count change | β | β | 0.3% | 8.4% | 17.7% | 20.4% |
| Financial health | ||||||
| Debt / equity | β | β | β | 0.9x | β | β |
| Quality scores | ||||||
| Accruals ratio | β | 33.9% | β27.8% | β15.9% | β6.9% | β1.6% |
Source: SEC EDGAR XBRL filings (CIK 0001259429). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.